Skip to main content
Top
Published in: Journal of Neural Transmission 12/2013

Open Access 01-12-2013 | Neurology and Preclinical Neurological Studies - Original Article

Loss of DARPP-32 and calbindin in multiple system atrophy

Authors: Hideki Hayakawa, Makiko Nagai, Aya Kawanami, Yasuto Nakata, Tomoko Nihira, Mieko Ogino, Masahiko Takada, Takaomi Saido, Jiro Takano, Makoto Saegusa, Tetsuo Mikami, Junichi Hamada, Kazutoshi Nishiyama, Hideki Mochizuki, Yoshikuni Mizuno

Published in: Journal of Neural Transmission | Issue 12/2013

Login to get access

Abstract

We evaluated the immunohistochemical intensities of α-synuclein, phosphorylated α-synuclein (p-syn), dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32), calbindin-D 28k, calpain-cleaved carboxy-terminal 150-kDa spectrin fragment, and tyrosine hydroxylase in multiple system atrophy (MSA). The caudate head, anterior putamen, posterior putamen, substantia nigra, pontine nucleus, and cerebellar cortex from six MSA brains, six age-matched disease control brains (amyotrophic lateral sclerosis), and five control brains were processed for immunostaining by standard methods. Immunostaining for α-synuclein, p-syn, or both was increased in all areas examined in oligodendrocytes in MSA. Immunostaining for DARPP-32 and calbindin-D 28k was most prominently decreased in the posterior putamen, where neuronal loss was most prominent. Immunostaining for DARPP-32 and calbindin-D 28k was also diminished in the anterior putamen and caudate head, where neuronal loss was less prominent or absent. Calbindin immunostaining was also decreased in the dorsal tier of the substantia nigra and cerebellar cortex. Loss of immunostaining for DARPP-32 and calbindin-D 28k compared with that of neurons indicates calcium toxicity and disturbance of the phosphorylated state of proteins as relatively early events in the pathogenesis of MSA.
Literature
go back to reference Adams R, VanBogaert L, Vandereecken H (1964) Striato-nigral degeneration. J Neruopathol Exp Neurol 23:584–608 Adams R, VanBogaert L, Vandereecken H (1964) Striato-nigral degeneration. J Neruopathol Exp Neurol 23:584–608
go back to reference Bertran-Gonzalez J, Bosch C, Maroteaux M, Matamales M, Herve D, Valjent E, Girault JA (2008) Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci 28:5671–5685. doi:10.1523/JNEUROSCI.1039-08.2008 PubMedCrossRef Bertran-Gonzalez J, Bosch C, Maroteaux M, Matamales M, Herve D, Valjent E, Girault JA (2008) Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci 28:5671–5685. doi:10.​1523/​JNEUROSCI.​1039-08.​2008 PubMedCrossRef
go back to reference Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D (28K) immunohistochemistry. Brain 122:1421–1436PubMedCrossRef Damier P, Hirsch EC, Agid Y, Graybiel AM (1999) The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D (28K) immunohistochemistry. Brain 122:1421–1436PubMedCrossRef
go back to reference DiFiglia M, Christakos S, Aronin N (1989) Ultrastructural localization of immunoreactive calbindin-D 28k in the rat and monkey basal ganglia, including subcellular distribution with colloidal gold labeling. J Comp Neurol 279:653–665. doi:10.1002/cne.902790411 PubMedCrossRef DiFiglia M, Christakos S, Aronin N (1989) Ultrastructural localization of immunoreactive calbindin-D 28k in the rat and monkey basal ganglia, including subcellular distribution with colloidal gold labeling. J Comp Neurol 279:653–665. doi:10.​1002/​cne.​902790411 PubMedCrossRef
go back to reference Farre-Castany MA, Schwaller B, Gregory P, Barski J, Mariethoz C, Eriksson JL, Tetko IV, Wolfer D, Celio MR, Schmutz I, Albrecht U, Villa AE (2007) Differences in locomotor behavior revealed in mice deficient for the calcium-binding proteins parvalbumin, calbindin D-28k or both. Behav Brain Res 178:250–261. doi:10.1016/j.bbr.2007.01.002 PubMedCrossRef Farre-Castany MA, Schwaller B, Gregory P, Barski J, Mariethoz C, Eriksson JL, Tetko IV, Wolfer D, Celio MR, Schmutz I, Albrecht U, Villa AE (2007) Differences in locomotor behavior revealed in mice deficient for the calcium-binding proteins parvalbumin, calbindin D-28k or both. Behav Brain Res 178:250–261. doi:10.​1016/​j.​bbr.​2007.​01.​002 PubMedCrossRef
go back to reference Garcia-Segura LM, Baetens D, Roth J, Norman AW, Orci L (1984) Immunohistochemical mapping of calcium-binding protein immunoreactivity in the rat central nervous system. Brain Res 296:75–86PubMedCrossRef Garcia-Segura LM, Baetens D, Roth J, Norman AW, Orci L (1984) Immunohistochemical mapping of calcium-binding protein immunoreactivity in the rat central nervous system. Brain Res 296:75–86PubMedCrossRef
go back to reference Girault JA, Raisman-Vozari R, Agid Y, Greengard P (1989) Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy. Proc Natl Acad Sci USA 86:2493–2497PubMedCrossRef Girault JA, Raisman-Vozari R, Agid Y, Greengard P (1989) Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy. Proc Natl Acad Sci USA 86:2493–2497PubMedCrossRef
go back to reference Greengard P, Allen PB, Nairn AC (1999) Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23:435–447PubMedCrossRef Greengard P, Allen PB, Nairn AC (1999) Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23:435–447PubMedCrossRef
go back to reference Honjo Y, Shirakashi Y, Kawamoto Y, Akiguchi I (2008) Anti-DARPP32 antibody-immunopositive inclusions in the brain of patients with multiple system atrophy. Clin Neuropathol 27:309–316PubMedCrossRef Honjo Y, Shirakashi Y, Kawamoto Y, Akiguchi I (2008) Anti-DARPP32 antibody-immunopositive inclusions in the brain of patients with multiple system atrophy. Clin Neuropathol 27:309–316PubMedCrossRef
go back to reference Ichimiya Y, Emson PC, Mountjoy CQ, Lawson DE, Heizmann CW (1988) Loss of calbindin-28K immunoreactive neurones from the cortex in Alzheimer-type dementia. Brain Res 475:156–159PubMedCrossRef Ichimiya Y, Emson PC, Mountjoy CQ, Lawson DE, Heizmann CW (1988) Loss of calbindin-28K immunoreactive neurones from the cortex in Alzheimer-type dementia. Brain Res 475:156–159PubMedCrossRef
go back to reference Inoue M, Yagishita S, Ryo M, Hasegawa K, Amano N, Matsushita M (1997) The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems. Acta Neuropathol 93:585–591PubMedCrossRef Inoue M, Yagishita S, Ryo M, Hasegawa K, Amano N, Matsushita M (1997) The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems. Acta Neuropathol 93:585–591PubMedCrossRef
go back to reference Ishikawa K, Mizusawa H, Fujita T, Ohkoshi N, Doi M, Komatsuzaki Y, Iwamoto H, Ogata T, Shoji S (1995) Calbindin-D 28k immunoreactivity in the cerebellum of spinocerebellar degeneration. J Neurol Sci 129:179–185PubMedCrossRef Ishikawa K, Mizusawa H, Fujita T, Ohkoshi N, Doi M, Komatsuzaki Y, Iwamoto H, Ogata T, Shoji S (1995) Calbindin-D 28k immunoreactivity in the cerebellum of spinocerebellar degeneration. J Neurol Sci 129:179–185PubMedCrossRef
go back to reference Ito H, Goto S, Sakamoto S, Hirano A (1992) Calbindin-D 28k in the basal ganglia of patients with Parkinsonism. Ann Neurol 32(4):543–550PubMedCrossRef Ito H, Goto S, Sakamoto S, Hirano A (1992) Calbindin-D 28k in the basal ganglia of patients with Parkinsonism. Ann Neurol 32(4):543–550PubMedCrossRef
go back to reference Karachi C, Francois C, Parain K, Bardinet E, Tande D, Hirsch E, Yelnik J (2002) Three-dimensional cartography of functional territories in the human striatopallidal complex by using calbindin immunoreactivity. J Comp Neurol 450:122–134. doi:10.1002/cne.10312 PubMedCrossRef Karachi C, Francois C, Parain K, Bardinet E, Tande D, Hirsch E, Yelnik J (2002) Three-dimensional cartography of functional territories in the human striatopallidal complex by using calbindin immunoreactivity. J Comp Neurol 450:122–134. doi:10.​1002/​cne.​10312 PubMedCrossRef
go back to reference McLachlan DR, Wong L, Bergeron C, Baimbridge KG (1987) Calmodulin and calbindin D 28K in Alzheimer disease. Alzheimer Dis Assoc Disord 1:171–179PubMedCrossRef McLachlan DR, Wong L, Bergeron C, Baimbridge KG (1987) Calmodulin and calbindin D 28K in Alzheimer disease. Alzheimer Dis Assoc Disord 1:171–179PubMedCrossRef
go back to reference McRitchie DA, Halliday GM (1995) Calbindin D 28k-containing neurons are restricted to the medial substantia nigra in humans. Neuroscience 65(1):87–91PubMedCrossRef McRitchie DA, Halliday GM (1995) Calbindin D 28k-containing neurons are restricted to the medial substantia nigra in humans. Neuroscience 65(1):87–91PubMedCrossRef
go back to reference Nakazato Y, Yamazaki H, Hirato J, Ishida Y, Yamaguchi H (1990) Oligodendroglial microtubular tangles in olivopontocerebellar atrophy. J Neuropathol Exp Neurol 49:521–530PubMedCrossRef Nakazato Y, Yamazaki H, Hirato J, Ishida Y, Yamaguchi H (1990) Oligodendroglial microtubular tangles in olivopontocerebellar atrophy. J Neuropathol Exp Neurol 49:521–530PubMedCrossRef
go back to reference Ouimet CC, Miller PE, Hemmings HC Jr, Walaas SI, Greengard P (1984) DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J Neurosci 4:111–124PubMed Ouimet CC, Miller PE, Hemmings HC Jr, Walaas SI, Greengard P (1984) DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J Neurosci 4:111–124PubMed
go back to reference Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L, Healy DG, Wood NW, Lees AJ, Holton JL, Revesz T (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 127:2657–2671. doi:10.1093/brain/awh303 PubMedCrossRef Ozawa T, Paviour D, Quinn NP, Josephs KA, Sangha H, Kilford L, Healy DG, Wood NW, Lees AJ, Holton JL, Revesz T (2004) The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 127:2657–2671. doi:10.​1093/​brain/​awh303 PubMedCrossRef
go back to reference Papp MI, Kahn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 94:79–100PubMedCrossRef Papp MI, Kahn JE, Lantos PL (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 94:79–100PubMedCrossRef
go back to reference Raisman-Vozari R, Girault JA, Moussaoui S, Feuerstein C, Jenner P, Marsden CD, Agid Y (1990) Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man. Brain Res 507:45–50PubMedCrossRef Raisman-Vozari R, Girault JA, Moussaoui S, Feuerstein C, Jenner P, Marsden CD, Agid Y (1990) Lack of change in striatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man. Brain Res 507:45–50PubMedCrossRef
go back to reference Saido TC, Yokota M, Nagao S, Yamaura I, Tani E, Tsuchiya T, Suzuki K, Kawashima S (1993) Spatial resolution of fodrin proteolysis in postischemic brain. J Biol Chem 268:25239–25243PubMed Saido TC, Yokota M, Nagao S, Yamaura I, Tani E, Tsuchiya T, Suzuki K, Kawashima S (1993) Spatial resolution of fodrin proteolysis in postischemic brain. J Biol Chem 268:25239–25243PubMed
go back to reference Sato K, Kaji R, Matsumoto S, Nagahiro S, Goto S (2007) Compartmental loss of striatal medium spiny neurons in multiple system atrophy of parkinsonian type. Mov Disord 22:2365–2370. doi:10.1002/mds.21732 PubMedCrossRef Sato K, Kaji R, Matsumoto S, Nagahiro S, Goto S (2007) Compartmental loss of striatal medium spiny neurons in multiple system atrophy of parkinsonian type. Mov Disord 22:2365–2370. doi:10.​1002/​mds.​21732 PubMedCrossRef
go back to reference Séquier JM, Hunziker W, Richards G (1988) Localization of calbindin D 28 mRNA in rat tissues by in situ hybridization. Neurosci Lett 86:155–160PubMedCrossRef Séquier JM, Hunziker W, Richards G (1988) Localization of calbindin D 28 mRNA in rat tissues by in situ hybridization. Neurosci Lett 86:155–160PubMedCrossRef
go back to reference Seto-Ohshima A, Emson PC, Lawson E, Mountjoy CQ, Carrasco LH (1988) Loss of matrix calcium-binding protein-containing neurons in Huntington’s disease. Lancet 8597:1252–1255CrossRef Seto-Ohshima A, Emson PC, Lawson E, Mountjoy CQ, Carrasco LH (1988) Loss of matrix calcium-binding protein-containing neurons in Huntington’s disease. Lancet 8597:1252–1255CrossRef
go back to reference Taniguchi S, Fujita Y, Hayashi S, Kakita A, Takahashi H, Murayama S, Saido TC, Hisanaga S, Iwatsubo T, Hasegawa M (2001) Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains. FEBS Lett 489:46–50PubMedCrossRef Taniguchi S, Fujita Y, Hayashi S, Kakita A, Takahashi H, Murayama S, Saido TC, Hisanaga S, Iwatsubo T, Hasegawa M (2001) Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains. FEBS Lett 489:46–50PubMedCrossRef
go back to reference Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H (1998) Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249:180–182PubMedCrossRef Wakabayashi K, Yoshimoto M, Tsuji S, Takahashi H (1998) Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci Lett 249:180–182PubMedCrossRef
go back to reference Walaas SI, Greengard P (1984) DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain. J Neurosci 4:84–98PubMed Walaas SI, Greengard P (1984) DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain. J Neurosci 4:84–98PubMed
go back to reference Wüllner U, Weller M, Kornhuber J, Bornemann A, Schulz JB, Riederer P, Klockgether T (2000) Altered expression of calcium- and apoptosis-regulating proteins in multiple system atrophy Purkinje cells. Mov Disord 15:269–275PubMedCrossRef Wüllner U, Weller M, Kornhuber J, Bornemann A, Schulz JB, Riederer P, Klockgether T (2000) Altered expression of calcium- and apoptosis-regulating proteins in multiple system atrophy Purkinje cells. Mov Disord 15:269–275PubMedCrossRef
Metadata
Title
Loss of DARPP-32 and calbindin in multiple system atrophy
Authors
Hideki Hayakawa
Makiko Nagai
Aya Kawanami
Yasuto Nakata
Tomoko Nihira
Mieko Ogino
Masahiko Takada
Takaomi Saido
Jiro Takano
Makoto Saegusa
Tetsuo Mikami
Junichi Hamada
Kazutoshi Nishiyama
Hideki Mochizuki
Yoshikuni Mizuno
Publication date
01-12-2013
Publisher
Springer Vienna
Published in
Journal of Neural Transmission / Issue 12/2013
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-013-1039-4

Other articles of this Issue 12/2013

Journal of Neural Transmission 12/2013 Go to the issue

Neurology and Preclinical Neurological Studies - Original Article

A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin®) in cervical dystonia